|
Guest
|
To: Durland.fish at (no spam) yale.edu, Aag1 at (no spam) columbia.edu, gary_wormser at (no spam) nymc.edu,
scientificintegrity at (no spam) ostp.gov, pkrugman at (no spam) princeton.edu,
Stanley.fish at (no spam) fiu.edu, emcsweegan at (no spam) niaid.nih.gov, afauci at (no spam) niaid.nih.gov,
SpinLyme at (no spam) yahoogroups.com, kshepard at (no spam) calea.org, fitzmas at (no spam) gmail.com,
patrick.fitzgerald at (no spam) usdoj.gov, modelt1918 at (no spam) sbcglobal.net,
jdrazen at (no spam) nejm.org, letters at (no spam) courant.com, Jgerberding at (no spam) cdc.gov,
michael.cole at (no spam) po.state.ct.us, conndcj at (no spam) po.state.ct.us, executive-
editor at (no spam) nytimes.com, managing-editor at (no spam) nytimes.com, news-
tips at (no spam) nytimes.com, bizday at (no spam) nytimes.com, foreign at (no spam) nytimes.com,
national at (no spam) nytimes.com, dvbid at (no spam) cdc.gov, brigidcallahan at (no spam) optonline.net,
trvl at (no spam) hotmail.com, illinoislyme at (no spam) aol.com, jlender at (no spam) courant.com,
tinajgarcia at (no spam) yahoo.com, jhornberger at (no spam) fff.org, thomas.carson at (no spam) usdoj.gov,
thomas.ryan at (no spam) po.state.ct.us, kurtzh at (no spam) washpost.com,
georgewill at (no spam) washpost.com, pj at (no spam) allegorypress.com,
commissioner.dcf at (no spam) po.state.ct.us, bransfield at (no spam) comcast.net,
vtsherr at (no spam) comcast.net, oca at (no spam) po.state.ct.us, freethinker at (no spam) charter.net,
scott.murphy at (no spam) po.state.ct.us, governor.rell at (no spam) po.state.ct.us,
attorney.general at (no spam) po.state.ct.us, randall.samborn at (no spam) usdoj.gov,
Robert.shiller at (no spam) yale.edu, editor at (no spam) greenwich-post.com,
harold.koh at (no spam) yale.edu, sedmonds at (no spam) nswbc.org, rrmcgovern at (no spam) aol.com,
frich at (no spam) nytimes.com, dprice at (no spam) stmartin.edu
Cc: francam at (no spam) ucia.gov, dr-ahmadinejad at (no spam) president.ir,
eugenerobinson at (no spam) washpost.com, afauci at (no spam) niaid.nih.gov,
bmiller at (no spam) newstimes.com, trvl at (no spam) hotmail.com, rastro18 at (no spam) aol.com,
billcurryct at (no spam) gmail.com, amcguigan at (no spam) rms-law.com, rjmurzyn at (no spam) aol.com,
paulcraigroberts at (no spam) yahoo.com, sidney_blumenthal at (no spam) yahoo.com,
criminal.division at (no spam) usdoj.gov, karla.dobinski at (no spam) usdoj.gov,
christopher.christie at (no spam) usdoj.gov, richard.Levin at (no spam) yale.edu,
harold.koh at (no spam) yale.edu, james.phillips at (no spam) yale.edu, inquire at (no spam) aldf.com,
lyme at (no spam) idsociety.org, meganmcardle at (no spam) theatlantic.com,
bob.drogin at (no spam) latimes.com
Subject: Harper's: Lieberman literally in bed with BigPharma
(SmithKline/LYMErix) and InsCo Hoes
Date: Oct 28, 2009 11:36 AM
Well, well, well. Joe in bed with
SmithKline, manufacturer of Yale's
vaccine for a disease that according
to Yale, "does not exist," but would
bring in $$*5*$$$ million a year in
royalties:
http://www.actionlyme.org/LYME_CORRUPTICUT.htm
We got EVERYBODY working against us
from duh non-spelling, non-reading DCF
to the DemoRepugnicant Senator from the
State of Israel.
KMDickson
http://www.actionlyme.org
================================
http://harpers.org/archive/2009/10/hbc-90005996
Lieberman Shills for the Healthcare Industry
By Scott Horton
When he was seeking reelection in 2006, Joe Lieberman campaigned as a
supporter of healthcare reform and expressed his support for
“universal healthcare.” When the rubber hit the road, however,
Lieberman emerged as a frontline warrior for the healthcare industry
in its efforts to block reform. Yesterday, he not only noted his
opposition to the very modest public option contained in the
legislation that Majority Leader Harry Reid put forward, he also
stated that he would cross the aisles to support a Republican
filibuster. Should we be surprised? No. Lieberman has long been one of
the industry’s favorite players on the hill, accepting more than $1
million in campaign contributions from the insurance industry and more
than $600,000 from pharmaceuticals and related healthcare-products
companies. But his ties run deeper than that. His wife Hadassah
previously worked for two lobbying firms, Hill & Knowlton and APCO,
handling matters for their healthcare and pharmaceuticals clients.
Throughout the 2006 campaign, Lieberman pointedly refused to discuss
the scope of his wife’s engagement for the healthcare industry or even
the specific clients for whom she was working. But there seems to have
been plenty of opportunity for synergy with Lieberman’s work in
Congress. Joe Conason noted:
Among Hill & Knowlton’s clients when Mrs. Lieberman signed on with
the firm last year was GlaxoSmithKline, the huge British-based drug
company that makes vaccines along with many other drugs. As I noted in
July, Sen. Lieberman introduced a bill in April 2005 (the month after
his wife joined Hill & Knowlton) that would award billions of dollars
in new “incentives” to companies like GlaxoSmithKline to persuade them
to make more new vaccines. Under the legislation, known as Bioshield
II, the cost to consumers and governments would be astronomical, but
for Lieberman and his Republican cosponsors, Sen. Orrin Hatch, R-Utah,
and Sen. Sam Brownback, R-Kan., the results would be worth every
penny. Using the war on terror as their ideological backdrop, the
pharma-friendly senators sought to win patent extensions on products
that have nothing to do with preparations against terrorist attack or
natural disaster.
As the New Haven Register, Lieberman’s hometown newspaper, noted
in an editorial headlined “Lieberman Crafts Drug Company Perk,” that
bill is even more generous to the pharmaceutical industry than a
similar proposal by the Senate Republican leadership. “The government
can offer incentives and guarantees for needed public health
measures,” it said. “But it should not write a blank check, as these
bills do, to the pharmaceutical industry that has such a large cost to
the public with what may be an uncertain or dubious return.” What the
editorial didn’t mention was that the Lieberman bill had also been
written by Chuck Ludlam, a former pharmaceutical industry lobbyist who
then worked on the Connecticut senator’s staff. From his office to his
bedroom, Lieberman was totally surrounded by current and former
employees of Big Pharma. Ludlam has since retired, and Mrs. Lieberman
has quit her job too — but Lieberman still looks like a politician
wholly owned by one of the nation’s most troublesome special
interests. And while his campaign may not believe that the moralizing
senator should he held accountable for those dubious relationships,
the press and the public may think otherwise.
Previous · Next · More No Comment · Respond via email
"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci |
|
|
